Skip to content
Cure SMA Canada
“Help for Today, Hope for Tomorrow”
Cure SMA Canada
  • Home
  • About us
  • About SMA
  • Treatments
    • Treatments
    • British Columbia treatments
    • Alberta treatments
    • Saskatchewan treatments
    • Manitoba treatments
    • Ontario treatments
    • Quebec treatments
    • Prince Edward Island treatments
    • New Brunswick treatments
    • Nova Scotia treatments
    • Newfoundland treatments
    • Yukon Territories treatments
    • Non-Insured Health Benefits for First Nations and Inuit treatments
  • Join CURESMA
  • Events
  • Resources
  • COVID-19
  • Donate
  • SMA Camp
  • Contact Us
  • Français
FacebookInstagramTwitterLinkedin
  • Home
  • About us
  • About SMA
  • Treatments
    • Treatments
    • British Columbia treatments
    • Alberta treatments
    • Saskatchewan treatments
    • Manitoba treatments
    • Ontario treatments
    • Quebec treatments
    • Prince Edward Island treatments
    • New Brunswick treatments
    • Nova Scotia treatments
    • Newfoundland treatments
    • Yukon Territories treatments
    • Non-Insured Health Benefits for First Nations and Inuit treatments
  • Join CURESMA
  • Events
  • Resources
  • COVID-19
  • Donate
  • SMA Camp
  • Contact Us
  • Français

Daily Archives: June 7, 2017

You are here:
  1. Home
  2. 2017
  3. June
  4. 07

European Commission (EC) granted a marketing authorization for SPINRAZA®

Research NewsBy ebessoJune 7, 2017Leave a comment

June 4, 2017 Dear members of the SMA community, In response to your request for information, we are delighted to inform you that on June 1 2017 Biogen announced that the European Commission (EC) granted a marketing authorization for SPINRAZA® (nusinersen) for the treatment of 5q spinal muscular atrophy (SMA) which is the most common…

© Copyright 2017 | Cure SMA Canada | All Rights Reserved : Designed by Ocean Marketing. A Montreal web design company

Website design and development by Ocean Marketing Inc

Go to Top